MedTrace Logo

ANAIS, a Spanish Version of the DAFNE Programme

NCT03699189 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2018-10-09

No results posted yet for this study

Summary

ANAIS is a therapeutic education programme for type 1 diabetes based on a flexible insulin regime adjusted to the patient's food intake. Participants are randomised in two groups, to attend the training course immediately (immediate ANAIS) or a year later (delayed ANAIS). The main outcome was HbA1c at one year.

Conditions

  • Diabetes Mellitus, Type 1

Interventions

BEHAVIORAL

Immediate ANAIS

ANAIS is a structured therapeutic education programme aimed at providing the patients with the necessary skills to manage their diabetes independently and confidently. The programme particularly promotes dietary freedom, in an intensive insulin regime, by enabling effective carbohydrate counting and accurate prandial insulin dose adjustment and avoiding hypoglycaemia. ANAIS was organised as a five day (Monday to Friday), seven-hour, outpatient programme using principles of adult education, with explicit learning objectives, in a group setting.

Sponsors & Collaborators

  • Ana M. Wägner

    collaborator UNKNOWN

  • Dácil Alvarado-Martel

    collaborator UNKNOWN

  • Yaiza López-Plasencia

    collaborator UNKNOWN

  • Armando Carrillo-Domínguez

    collaborator UNKNOWN

  • Julia Rodríguez-Cordero

    collaborator UNKNOWN

  • Francisco J Nóvoa-Mogollón

    collaborator UNKNOWN

  • Angelines Jiménez-Rodríguez

    collaborator UNKNOWN

  • Rosa María Sánchez Hernández

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2015-02-28
Completion
2015-02-28

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03699189 on ClinicalTrials.gov